BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16208856)

  • 1. More support for vascular basis of Alzheimer's disease.
    Becker-Barroso E
    Lancet Neurol; 2005 Oct; 4(10):598-9. PubMed ID: 16208856
    [No Abstract]   [Full Text] [Related]  

  • 2. Cerebrovascular effects of amyloid-beta peptides: mechanisms and implications for Alzheimer's dementia.
    Iadecola C
    Cell Mol Neurobiol; 2003 Oct; 23(4-5):681-9. PubMed ID: 14514024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrovascular damage as a cause for Alzheimer's disease.
    Humpel C; Marksteiner J
    Curr Neurovasc Res; 2005 Oct; 2(4):341-7. PubMed ID: 16181125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linking cerebrovascular defense mechanisms in brain ageing and Alzheimer's disease.
    Kalaria RN
    Neurobiol Aging; 2009 Sep; 30(9):1512-4. PubMed ID: 18187235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurovascular unit dysfunction: a vascular component of Alzheimer disease?
    Brenner SR
    Neurology; 2008 Jan; 70(3):243-4. PubMed ID: 18195273
    [No Abstract]   [Full Text] [Related]  

  • 6. Age-dependent cerebrovascular abnormalities and blood flow disturbances in APP23 mice modeling Alzheimer's disease.
    Beckmann N; Schuler A; Mueggler T; Meyer EP; Wiederhold KH; Staufenbiel M; Krucker T
    J Neurosci; 2003 Sep; 23(24):8453-9. PubMed ID: 13679413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral amyloid angiopathy: pathogenesis and effects on the ageing and Alzheimer brain.
    Weller RO; Nicoll JA
    Neurol Res; 2003 Sep; 25(6):611-6. PubMed ID: 14503015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparan sulfate proteoglycan expression in cerebrovascular amyloid beta deposits in Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis (Dutch) brains.
    van Horssen J; Otte-Höller I; David G; Maat-Schieman ML; van den Heuvel LP; Wesseling P; de Waal RM; Verbeek MM
    Acta Neuropathol; 2001 Dec; 102(6):604-14. PubMed ID: 11761721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of angiogenic vessels in Alzheimer's disease.
    Desai BS; Schneider JA; Li JL; Carvey PM; Hendey B
    J Neural Transm (Vienna); 2009 May; 116(5):587-97. PubMed ID: 19370387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's dementia by circulation disorders: when trees hide the forest.
    Dotti CG; De Strooper B
    Nat Cell Biol; 2009 Feb; 11(2):114-6. PubMed ID: 19188916
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of beta-amyloid fibrils on the interactions between red blood cells and endothelial cells.
    Ravi LB; Mohanty JG; Chrest FJ; Jayakumar R; Nagababu E; Usatyuk PV; Natarajan V; Rifkind JM
    Neurol Res; 2004 Jul; 26(5):579-85. PubMed ID: 15265278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasoactive effects of A beta in isolated human cerebrovessels and in a transgenic mouse model of Alzheimer's disease: role of inflammation.
    Paris D; Humphrey J; Quadros A; Patel N; Crescentini R; Crawford F; Mullan M
    Neurol Res; 2003 Sep; 25(6):642-51. PubMed ID: 14503019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the difference between PART and Alzheimer's disease lie in the age-related changes in cerebral arteries that trigger the accumulation of Aβ and propagation of tau?
    Weller RO; Hawkes CA; Carare RO; Hardy J
    Acta Neuropathol; 2015 May; 129(5):763-6. PubMed ID: 25814152
    [No Abstract]   [Full Text] [Related]  

  • 14. Environmental enrichment counteracts Alzheimer's neurovascular dysfunction in TgCRND8 mice.
    Herring A; Yasin H; Ambrée O; Sachser N; Paulus W; Keyvani K
    Brain Pathol; 2008 Jan; 18(1):32-9. PubMed ID: 17924982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-accumulation of vascular endothelial growth factor with beta-amyloid in the brain of patients with Alzheimer's disease.
    Yang SP; Bae DG; Kang HJ; Gwag BJ; Gho YS; Chae CB
    Neurobiol Aging; 2004 Mar; 25(3):283-90. PubMed ID: 15123332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of oxidative stress in the pathophysiology of cerebrovascular lesions in Alzheimer's disease.
    Aliev G; Smith MA; Seyidov D; Neal ML; Lamb BT; Nunomura A; Gasimov EK; Vinters HV; Perry G; LaManna JC; Friedland RP
    Brain Pathol; 2002 Jan; 12(1):21-35. PubMed ID: 11770899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid beta-protein induces the cerebrovascular cellular pathology of Alzheimer's disease and related disorders.
    Van Nostrand WE; Davis-Salinas J; Saporito-Irwin SM
    Ann N Y Acad Sci; 1996 Jan; 777():297-302. PubMed ID: 8624102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiological levels of beta-amyloid induce cerebral vessel dysfunction and reduce endothelial nitric oxide production.
    Price JM; Chi X; Hellermann G; Sutton ET
    Neurol Res; 2001 Jul; 23(5):506-12. PubMed ID: 11474807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-amyloid, blood vessels, and brain function.
    Smith EE; Greenberg SM
    Stroke; 2009 Jul; 40(7):2601-6. PubMed ID: 19443808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A link between sICAM-1, ACE and parietal blood flow in the aging brain.
    Janciauskiene SM; Erikson C; Warkentin S
    Neurobiol Aging; 2009 Sep; 30(9):1504-11. PubMed ID: 18243419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.